Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes.

ABSTRACT:

Background

Cardiovascular disease (CVD), particularly ischemic heart disease, remains the leading cause of death and morbidity in patients with type 1 diabetes. Detecting subclinical atherosclerosis could enhance cardiovascular risk stratification and enable individualised therapies. The aim of this study is to investigate the prevalence and predictors of subclinical atherosclerosis in patients with type 1 diabetes without overt cardiovascular disease (CVD) and to assess its impact on patient survival over a follow-up period of at least 5 years.

Methods

This observational study included 507 patients treated at the Diabetes Unit of the Hospital of Girona Doctor Josep Trueta between 2015 and 2023. The inclusion criteria for patients were as follows: those aged 18 and older wit

SUBMITTER: Sojo-Vega L 

PROVIDER: S-EPMC11488122 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature